MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Utilization of Healthcare and Deep Brain Stimulation in Black and White Patients with Parkinson’s Disease

    M. Padmanaban, C. Liao, J. Johnson, K. Booker, M. Rizig, W. Abou Chaar, J. Bundy, H. Leeper, P. Warnke, B. Chiu, T. Xie (Chicago, USA)

  • Utilization of Phosphorylated Alpha-Synuclein Skin Biopsy Testing in a Movement Disorders Center

    S. Anis, A. Kundrick, C. Piccinin, T. Lopez-Gonzalez, D. Dos Santos, H. Fernandez (Cleveland, USA)

  • Utilizing the 15-item modification of the PSPRS rating scale (mPSPRS-15) as the primary endpoint for future clinical trials in progressive supranuclear palsy

    F. Nery, T. Nevmyrych, J. Murphy, S. Wu, Y. Zabar, A. Gafson, S. Bullain, J. O’Gorman (Cambridge, USA)

  • Utilizing the Global Parkinson’s Genetics Program (GP2) to develop a precision medicine recruitment protocol

    K. Atterling Brolin, YY. Beh, P. Saffie Awad, J. Aviles, A. Pajo, E. Navarro-Jones, C. Klein, I. F. Mata, K. Paquette, H. Iwaki, L. Jones, H. Leonard, N. Okubadejo, C. Blauwendraat, L. Screven, A. Noyce, M. Toffoli, AH. Tan, H. Morris, M. Nalls (Lund, Sweden)

  • Utilizing the Levodopa Challenge Test to Clarify Clinical Complaints Following Levodopa Administration: A Case Series

    M. da Silva, C. Ternes, B. de Lima, R. Mesquita, L. Moriyama (Campinas, Brazil)

  • Utilizing Virtual Reality in Educational Programs for Parkinson’s Disease Rehabilitation: A Review of Current Literature and Future Directions

    S. A. Hassan, Y. Mohamed, M. Abouelseoud, A. Alaa, A. Hafez, M. M. Elsayed (Giza, Egypt)

  • Vagus nerve ultrasound and its association with non-motor symptoms in parkinson’s disease

    S. Garcia, J. Sanchez, J. Grandas (MADRID, Spain)

  • Valbenazine Improves Chorea Across Multiple Body Regions in Adults With Huntington’s Disease

    E. Furr Stimming, E. Kayson, R. Mehanna, J. Goldstein, S. Hinton, O. Klepitskaya, H. Zhang, D. Haubenberger (Houston, USA)

  • Valbenazine Improves the Burden and Symptoms of Tardive Dyskinesia: Topline Results from the Phase 4 KINECT-PRO Study

    E. Dunayevich, A. Parameswaran, M. Bron, E. Franey, D. Sparta, C. Zeng, S. Mathias, J. Mcevoy (San Diego, USA)

  • Validating Real-World Evidence for Identifying Adverse Events Related to a Deep Brain Stimulation Implant

    J. Joseph, Y. Pathak, C. Salazar, A. Benison (Plano, USA)

  • « Previous Page
  • 1
  • …
  • 174
  • 175
  • 176
  • 177
  • 178
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley